Given the importance of C. difficile toxins to the pathogenesis of CDI, we hypothesized that MET-1 and DEC58 components may mediate therapeutic effects through antagonistic mechanisms on the expression, regulation, or production of C. difficile TcdA and TcdB independent of host-associated factors. The gene discussed is GZMM; the disease is clostridium difficile infection.